Medicine guide
Ervebo
·
- Prescription status not stated
- Active substance
- Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP, live)
- Made by
- Merck Sharp & Dohme B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Ervebo is indicated for active immunization of individuals 1 year of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola virus. The use of Ervebo should be in accordance with official recommendations.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Merck Sharp & Dohme B.V. |
|---|---|
| Active substance | Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP, live) |
| Authorised on | 2019-11-11 |
| Last updated by the regulator | 2026-01-16 |
| EMA product number | EMEA/H/C/004554 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).